AIT Guidelines - Allergic Asthma

Dear Colleagues,

The European Academy of Allergy and Clinical Immunology has developed a clinical practice guideline that aims to provide evidence-based recommendations for the use of AIT as an adjunct treatment for allergic asthma.

This guideline has been developed by a multi-disciplinary working expert group and applies the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.

The aim of this Guideline is to provide evidence-based clinical recommendations for use of AIT in the treatment of allergic asthma and to identify gaps in knowledge, implementation barriers, unmet needs and future perspectives.

The entire allergy community, related specialties and representatives of industry are invited to review and comment on the manuscript draft provided. The deadline for your comments is Monday November 19 (please send them to This email address is being protected from spambots. You need JavaScript enabled to view it.).

Please access the guidelines below:
EAACI guidelines on Allergen Immunotherapy: House dust mites driven Allergic Asthma
Appendix 1
Appendix 2
Appendix 3
Appendix 4
Appendix 5
Appendix 6

Looking forward hearing from you.

EAACI AIT Asthma Guidelines Chairs
Ioana Agache, Susanne Lau and Marek Jutel

Last updated 06 November 2018
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Send feedback